Second Malignant Neoplasms: Assessment and Strategies for Risk ReductionMarie Wood, Lois B. Travis, Victor G. Vogel et al.|Journal of Clinical Oncology|2012Cited by 336
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024Mary B. Daly, Susan Darlow, Banu Arun et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 284
A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.Karen Kelly, Paul A. Bunn, Zhaoxing Pan et al.|PubMed|1999Cited by 28